A study illustrating potential molecular targets in glioblastoma has reported that the PI3K/AKT/mTOR pathway is the most significant target compared to other culprits even mutated P53 so that this pathway is overexpressed in 90% of GBM cases (27). The gene discussed is MTOR; the disease is glioblastoma.